Furthermore, IHC analysis revealed a progressive increase in IDO1 expression and the numbers of Tregs in the third generation of tumors (S3), which is indicative of tumor immune evasion and the potentially suboptimal efficacy of STING agonists (Supplemental Figure 6D). This evidence concerns the gene STING1 and neoplasm.